Vishnu Priya Veeraraghavan
Overview
Explore the profile of Vishnu Priya Veeraraghavan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
206
Citations
940
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jayaraman S, Prasad M, Natarajan S, Krishnamoorthy R, Alshuniaber M, Gatasheh M, et al.
Chem Biol Interact
. 2025 Feb;
411:111443.
PMID: 39986364
Diabetic nephropathy, a severe problem of diabetes mellitus, is exacerbated by high-fat diets, prompting a need for interventions. Previous study from our laboratory has shown that β-sitosterol, a potent plant...
2.
Mony U, Veeraraghavan V
Crit Rev Oncol Hematol
. 2025 Feb;
209:104671.
PMID: 39978425
Background: Tumor-infiltrating lymphocyte (TIL) treatment is an individualized method of treating different types of solid tumors by using the immune system of the body to target and destroy cancer cells....
3.
Hema Shree K, Gayathri R, Veeraraghavan V, Ramani P, Ramadoss R, Yuwanati M
Arch Oral Biol
. 2025 Feb;
173:106196.
PMID: 39961150
Objectives: To assess the efficacy of the AuNP-enhanced ELISA in the detection of salivary TNF-α in OSCC and evaluate its predictive value for survival. Design: A longitudinal study was conducted...
4.
D S, Veeraraghavan V, Surapaneni K, Prashar L, Mony U
Int J Surg
. 2025 Feb;
PMID: 39945774
No abstract available.
5.
Ealla K, Durga C, Sahu V, Kumari N, Venkatesan J, Veeraraghavan V, et al.
BMC Oral Health
. 2025 Feb;
25(1):177.
PMID: 39893416
Background: Tooth extraction, a common dental procedure, is often accompanied by pain, trismus, and swelling due to alveolitis caused by oral bacteria. Doxycycline is prescribed to alleviate infection and improve...
6.
Veeraraghavan V, Jayaraman S, Marrapodi M, Ronsivalle V, Cicciu M, Minervini G
Minerva Dent Oral Sci
. 2025 Jan;
PMID: 39829295
Background: Oral cancer is a predominant and aggressive form of head and neck cancer with limited treatment options. Stevioside, a naturally occurring biocompatible compound, has gained attention for its potential...
7.
Manivannan H, Veeraraghavan V, Francis A
Appl Biochem Biotechnol
. 2025 Jan;
PMID: 39820926
The primary objective of this study was to identify bioactive compounds from four medicinal plants with multi-targeting activity against hepatocellular carcinoma (HCC). A comprehensive analysis led to the identification of...
8.
Muthusamy M, Ramani P, Arumugam P, Rudrapathy P, Kangusamy B, Veeraraghavan V, et al.
BMC Oral Health
. 2025 Jan;
25(1):62.
PMID: 39800703
Background: Oral squamous cell carcinoma (OSCC) is one of the most prevalent oral cancers in the world. The major etiological factors are considered to be tobacco and alcohol. However, the...
9.
P J N, Patil S, Veeraraghavan V, Daniel S, Aileni K, Karobari M
Eur J Pharmacol
. 2025 Jan;
989():177222.
PMID: 39755243
Oral squamous cell carcinoma (OSCC) remains a major cause of morbidity and mortality worldwide with high recurrence rates and resistance to conventional therapies. Recent studies have highlighted the pivotal role...
10.
Yuktha A, Bandari S, Fathima S, Selvaraj J, Veeraraghavan V, Dasari A, et al.
Asian Pac J Cancer Prev
. 2024 Nov;
25(11):3997-4003.
PMID: 39611924
Background: Oral squamous cell carcinoma (OSCC) is a prevalent malignancy with high morbidity and mortality rates. Timely diagnosis is critical for improving patient outcomes; however, diagnostic delays remain a concern....